Ventyx Biosciences (VTYX)
NASDAQ:VTYX
US Market

Ventyx Biosciences Financial Statements

29 Followers

Ventyx Biosciences Financial Overview

Ventyx Biosciences's market cap is currently ―. The company's EPS TTM is $-1.785; its P/E ratio is -16.55; Ventyx Biosciences is scheduled to report earnings on March 22, 2023, and the estimated EPS forecast is $-0.60. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -30.46M$ -20.02M$ -22.73M$ -17.77M$ -12.77M
EBITDA$ -30.34M$ -19.91M$ -22.64M$ -17.75M$ -12.77M
Net Income Common Stockholders$ -30.46M$ -20.02M$ -22.73M$ -17.77M$ -12.77M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 412.42M$ 250.45M$ 254.35M$ 258.58M$ 141.95M
Total Assets$ 420.44M$ 262.19M$ 277.95M$ 291.48M$ 148.71M
Total Debt$ 1.65M$ 1.75M$ 1.32M$ 0.00$ 0.00
Net Debt$ -410.78M$ -248.71M$ -253.03M$ -258.58M$ -141.95M
Total Liabilities$ 36.91M$ 19.03M$ 18.83M$ 12.28M$ 236.33M
Stockholders Equity$ 383.53M$ 243.15M$ 259.12M$ 279.20M$ -87.62M
Cash Flow
Free Cash Flow$ -24.09M$ -14.82M$ -12.76M$ -14.75M$ -11.22M
Operating Cash Flow$ -23.99M$ -14.79M$ -12.73M$ -14.70M$ -11.02M
Investing Cash Flow$ 64.16M$ 18.25M$ -16.50M$ -143.09M$ -73.16M
Financing Cash Flow$ 177.79M$ 249.00K$ 86.00K$ 159.58M$ 50.38M
Currency in USD

Ventyx Biosciences Earnings and Revenue History


Ventyx Biosciences Debt to Assets


Ventyx Biosciences Cash Flow


Ventyx Biosciences Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis